(Invented) Name Strength Pharmaceutical Form. 3 mg/3 ml Solution for injection. Kytril 2 mg - Filmtabletten 2 mg Film-coated tablet Oral use

Similar documents
List of nationally authorised medicinal products

(Invented) Name. Crestor 5 mg Filmtabletten. Filmtabletten. Filmtabletten. Filmtabletten. Crestor 5 mg Film coated tablets Oral use

ANNEX II THE MANUFACTURING AUTHORISATION HOLDERS RESPONSIBLE FOR IMPORT AND BATCH RELEASE AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE

Annex I. List of nationally authorised medicinal products and marketing authorisation applications

List of nationally authorised medicinal products

Member State Marketing autorisation Holder Invented Name Strength Pharmaceutical form Route of administration

4,0 g/0,5 g. 2g/250 mg. 4 g/500 mg. 4g/0,5g 2.25 G/VIAL. injection 4.5 G/VIAL. injection. injection

Member State Marketing Authorisation Holder (Invented) Strength Pharmaceutical form Route of administration. Novartis Pharma NV

Powder for solution for infusion. Powder and solvent for solution for IM injection. Powder and solvent for solution for IV injection

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tamiflu 12 mg/ml powder for oral suspension oseltamivir

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tamiflu 12 mg/ml powder for oral suspension. oseltamivir

PACKAGE LEAFLET: INFORMATION FOR THE USER. Xenical 120mg hard capsules Orlistat

List of nationally authorised medicinal products

Package leaflet: Information for the user

Annex I. List of nationally authorised medicinal products and marketing authorisation applications

List of nationally authorised medicinal products

Package Leaflet: Information for the user. Perjeta 420 mg concentrate for solution for infusion pertuzumab

(Invented) Name Strength Pharmaceutical form

Marketing Authorisation Holder Invented name Strength Pharmaceutical Form. Postinor 1500 Mikrogramm-Tablette

Package leaflet: Information for the user Esbriet 267 mg hard capsules Pirfenidone

PACKAGE LEAFLET: INFORMATION FOR THE USER. Xenical 120mg hard capsules Orlistat

List of nationally authorised medicinal products

List of nationally authorised medicinal products

1. What MabThera is and what it is used for

Package leaflet: Information for the patient. Cotellic 20 mg film-coated tablets cobimetinib

Sortis 10 mg - Filmtabletten. Sortis 20 mg - Filmtabletten. Sortis 40 mg - Filmtabletten. Sortis 80 mg - Filmtabletten

BONVIVA 150 mg film-coated tablets

List of nationally authorised medicinal products

Marketing Authorisation Holder (Invented) name Strength Pharmaceutical Form Route of administration Novartis Pharma GmbH

Tadim 1 Million I.E. Pulver zur Herstellung einer Infusionslösung. Tadim 1 Million I.E. Pulver zur Herstellung einer Lösung für einen Vernebler

List of nationally authorised medicinal products

Package leaflet: Information for the patient. Tecentriq 1,200 mg concentrate for solution for infusion atezolizumab

PACKAGE LEAFLET: INFORMATION FOR THE USER. Xenical 120mg hard capsules Orlistat

PACKAGE LEAFLET: INFORMATION FOR THE USER. Xenical 120mg hard capsules Orlistat

Package leaflet: Information for the patient. Ocrevus 300 mg concentrate for solution for infusion Ocrelizumab

(Invented) Name Strength Pharmaceutical form. Ergotop 10 mg - Tabletten. Ergotop 20 mg - Filmtabletten. Ergotop 30 mg - Filmtabletten

List of nationally authorised medicinal products

PACKAGE LEAFLET: INFORMATION FOR THE USER. Herceptin 600 mg solution for injection in vial Trastuzumab

Package Leaflet: Information for the user. Tamiflu 6 mg/ml powder for oral suspension oseltamivir

Package leaflet: Information for the user. Hemlibra 150 mg/ml solution for injection. emicizumab

Package Leaflet: Information for the user. Tamiflu 6 mg/ml powder for oral suspension oseltamivir

B. PACKAGE LEAFLET 25

Package leaflet: Information for the user. Zelboraf 240 mg film-coated tablets vemurafenib

Invented name Strength. 125mg/5ml. 250mg/5ml

Package leaflet: Information for the patient. Levocetirizine Krka 5 mg film-coated tablets Levocetirizine dihydrochloride

Package leaflet: Information for the user. Xeloda 150 mg film-coated tablets Xeloda 500 mg film-coated tablets capecitabine

Marketing Authorisation Holder Invented name Strength Pharmaceutical Form

(Invented) Name Strength Pharmaceutical form. Effortil comp. - Tropfen 2 mg/ml, 10 mg/ml. 2.5 mg prolonged-release capsule, hard

Package leaflet: Information for the patient. MabThera 100 mg concentrate for solution for infusion rituximab

Package leaflet: Information for the user. Myozyme 50 mg powder for concentrate for solution for infusion Alglucosidase alfa

List of nationally authorised medicinal products

Package leaflet: Information for the patient. Xydalba 500 mg powder for concentrate for solution for infusion dalbavancin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Herceptin 150 mg powder for concentrate for solution for infusion Trastuzumab

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the patient. Fuzeon 90 mg/ml powder and solvent for solution for injection Enfuvirtide

ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCT, ROUTES OF ADMINISTRATION, APPLICANTS IN THE MEMBER STATES

Package leaflet: Information for the user. Sevelamer carbonate Zentiva 800 mg film-coated tablets sevelamer carbonate

Package leaflet: Information for the user. Renvela 800 mg film-coated tablets sevelamer carbonate

Package leaflet: Information for the user CellCept 1 g/5 ml powder for oral suspension (mycophenolate mofetil)

List of nationally authorised medicinal products

Package leaflet: Information for the patient. Gazyvaro 1,000 mg concentrate for solution for infusion Obinutuzumab

Package leaflet: Information for the patient. Zeffix 100 mg film-coated tablets lamivudine

1. What RoActemra is and what it is used for

List of nationally authorised medicinal products

Package leaflet: Information for the patient. Integrilin 2 mg/ml solution for injection eptifibatide

Package leaflet: Information for the patient. Tadalafil Mylan 2.5 mg film-coated tablets Tadalafil

List of nationally authorised medicinal products

Package leaflet: Information for the user. Naloxone 400 microgram/ml solution for injection or infusion naloxone hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. NALOXONE 400 microgram/ml solution for injection or infusion. naloxone hydrochloride

INN Product name Strength Pharmaceutical form

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Aurobindo 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride

Orlistat EG 60 mg capsule, hard oral use. Orlistat EG 120 mg capsule, hard oral use. Orlistat Sandoz 60 mg capsule, hard oral use

Product name Strength Pharmaceutical form. Flupirtinmaleat AbZ 100 mg Kapseln. Flupirtinmaleat AL 100 mg Hartkapseln. Awegal inject 164,5 mg / 3 ml

1. What RoActemra is and what it is used for

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the user. Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal)

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER. AZILECT 1 mg tablets Rasagiline

Package leaflet: Information for the patient

PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER. chloroprocaine hydrochloride

B. PACKAGE LEAFLET 21

leflunomide Package leaflet: Information for the user Leflunomide Winthrop 20 mg film-coated tablets

Marketing Authorisation Holder Invented name Strength Pharmaceutical Form. Postinor 1500 Mikrogramm-Tablette

PACKAGE LEAFLET: INFORMATION FOR THE USER. Savene 20 mg/ml powder for concentrate and diluent for solution for infusion.

PACKAGE LEAFLET: INFORMATION FOR THE USER. CIALIS 10 mg film-coated tablets tadalafil

Cosaar 12,5 mg - Filmtabletten. Cosaar 50 mg - Filmtabletten. Cosaar 100 mg - Filmtabletten COZAAR CARDIO START. 21 X 12,5 mg + 14 X 50 mg

Package leaflet: Information for the user. Hemlibra 30 mg/ml solution for injection. emicizumab

PACKAGE LEAFLET For medicinal products available on prescription

Package leaflet: Information for the user. Clopidogrel Mylan 75 mg film-coated tablets clopidogrel

PACKAGE LEAFLET: INFORMATION FOR THE USER ALBUNORM 20% 200 g/l, Solution for infusion Human albumin

List of nationally authorised medicinal products

List of nationally authorised medicinal products

List of nationally authorised medicinal products

Annex I. Article 107i of Directive 2001/83/EC. Procedure number: EMEA/H/A-107i/ March 2013 EMA/147828/2013 Patient Health Protection

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

Package leaflet: Information for the user. Rhesonativ 625 IU/ml, solution for injection Human anti-d immunoglobulin

Package leaflet: Information for the user. Benlysta 120 mg powder for concentrate for solution for infusion

Package leaflet: Information for the patient

Smokefree Policies in Europe: Are we there yet?

Transcription:

ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES 1

Austria Austria Bulgaria Bulgaria Czech Republic Czech Republic Roche Austria GmbH, Kytril 3 mg - Engelhorngasse 3, 1211 Wien Injektionslösung Austria Roche Austria GmbH, Engelhorngasse 3, 1211 Wien Austria Roche Bulgaria EOOD, 16 Bialo Pole Str. 1618 Sofia Bulgaria Roche Bulgaria EOOD, 16 Bialo Pole Str. 1618 Sofia Bulgaria Roche s.r.o., Dukelských hrdinů 52 170 00 Praha 7 Czech Republic Roche s.r.o., Dukelských hrdinů 52 170 00 Praha 7 Czech Republic 3 mg/3 ml Solution for Kytril 2 mg - Filmtabletten 2 mg Film-coated tablet Oral use Kytril solution injectable Kytril 3 mg/3 ml solution injectable Kytril 1 mg comprimés pelliculés 1 mg Solution for 3 mg Solution for Kytril 1 mg / ml Solution for /infusion Kytril 2 mg 2 mg Film-coated tablet Oral use Kytril inj./inf Solution for /infusion 3 ml 3 mg/3 ml 1 ml (1 mg/ ml) 3 ml (1 mg/ ml) 2

Estonia Estonia Roche Eesti OÜ Lõõtsa 2, 11415 Tallinn Estonia Roche Eesti OÜ Lõõtsa 2, 11415 Tallinn Estonia Roche Oy PL 12 02181 Espoo Roche Oy PL 12 02181 Espoo Roche Oy PL 12 02181 Espoo ROCHE 52 Boulevard du Parc 92521 NEUILLY SUR SEINE cedex ROCHE 52 Boulevard du Parc 92521 NEUILLY SUR SEINE cedex ROCHE 52 Boulevard du Parc 92521 NEUILLY SUR SEINE cedex Kytril 1mg/ml Concentrate for /infusion Kytril 1mg Film-coated tablet Oral use Kytril Kytril Solution for Kytril 3mg/3ml solution injectable pour voie intraveineuse Kytril 1mg/ comprimé pelliculé Kytril 2 mg comprimé pelliculé 3mg/3ml Solution for 2 mg Film-coated tablet Oral use 1mg/ml (1ml and 3ml) 5x1 ml and 5x3 ml 3mg/3ml 3

Roche Pharma AG Emil-Barell-Straße 1 79639 Grenzach-Wyhlen Roche Pharma AG Emil-Barell-Straße 1 79639 Grenzach-Wyhlen Roche Pharma AG Emil-Barell-Straße 1 79639 Grenzach-Wyhlen Greece Roche (Hellas ) A.E. Alamanas 4 & Delfon, 15125 Maroussi Greece Greece Roche (Hellas ) A.E. Alamanas 4 & Delfon, 15125 Maroussi Greece Greece Roche (Hellas ) A.E. Alamanas 4 & Delfon, 15125 Maroussi Greece Greece Roche (Hellas ) A.E. Alamanas 4 & Delfon, 15125 Maroussi Greece Hungary Roche (Hungary) Ltd H-2040 Budaörs Edison u. 1. Hungary Kevatril 1 mg Solution for Injektionslösung Kevatril Filmtabletten 2 mg 2 mg Film-coated tablet Oral use Kevatril 3 mg Solution for 3 mg/3 ml Injektionslösung Kytril 1mg Film-coated tablet Oral use Kytril 1mg/1ml Solution for Kytril 3mg/3ml Solution for Kytril 1 ml 3 ml 1mg/1ml 3mg/3ml 4

Hungary Ireland Ireland Ireland Ireland Roche (Hungary) Ltd H-2040 Budaörs Edison u. 1. Hungary Roche S.p.A. Piazza Durante 11 20131 Milano Roche S.p.A. Piazza Durante 11 20131 Milano Roche S.p.A. Piazza Durante 11 20131 Milano Kytril 3 mg/3 ml Solution for Kytril Tablets 1mg 1mg Film-coated tablet Oral use Kytril Tablets 2mg 2mg Film-coated tablet Oral use Kytril Ampoules concentrate for infusion or Kytril Infusion 3 mg/3 ml concentrate for infusion or 1mg/1ml 3mg/3ml Concentrate for infusion/ Concentrate for infusion/ Kytril 3 mg/3 ml Solution for Kytril Solution for Kytril 3 mg/5 ml Solution for 3 mg/3 ml 1ml contains 1mg granisetron (hydrochloride) 1mg contains 9mg sodium chloride = 3.54 mg sodium 3ml contains 3mg granisetron (hydrochloride) 3ml contains 27mg sodium chloride = 10.62 mg sodium 3 mg/3 ml 3 mg/5 ml 5

Latvia Latvia Luxembourg Luxembourg Roche S.p.A. Piazza Durante 11 20131 Milano Roche S.p.A. Piazza Durante 11 20131 Milano Roche Latvija SIA G. Astras 8b Riga, LV-1082 Latvia Roche Latvija SIA G. Astras 8b Riga, LV-1082 Latvia UAB Roche Lietuva J. Jasinskio 16b, LT-01112 Vilnius UAB Roche Lietuva J. Jasinskio 16b, LT-01112 Vilnius UAB Roche Lietuva J. Jasinskio 16b, LT-01112 Vilnius Kytril Kytril Kytril 1 mg film-coated tablets Solution for Kytril 1mg Film-coated tablet Oral use Kytril 1mg/ml Solution for /infusion Kytril 3mg/3ml Solution for /infusion Kytril solution injectable Kytril 3 mg/3 ml solution injectable 1 mg Solution for 3 mg Solution for 3 mg/3 ml 3 mg/3 ml 6

Luxembourg Malta Malta Kytril 1 mg comprimés pelliculés Roche Nederland B.V., Kytril i.v. 3 mg = 3 ml, Postbus 44, 3440 AA Woerden oplossing voor injectie Roche Nederland B.V., Kytril i.v. 1 mg = 1 ml, Postbus 44, 3440 AA Woerden oplossing voor injectie Roche Nederland B.V., Kytril 1 mg tabletten, Postbus 44, 3440 AA Woerden omhulde tabletten Roche Nederland B.V., Kytril 2 mg tabletten, Postbus 44, 3440 AA Woerden omhulde tabletten Roche Farmacêutica Química, Lda Estrada nacional 249-1, 2720-413, Amadora Roche Farmacêutica Química, Lda Estrada nacional 249-1, 2720-413, Amadora Kytril Tablets 1mg 1mg Film-coated tablet Oral use Kytril Injection 3mg/3ml 3mg/3ml Concentrate for infusion/ Solution for Solution for 2 mg Film-coated tablet Oral use Kytril 1ml contains 1mg granisetron (hydrochloride) 7

Romania Romania Slovak Republic Slovak Republic Slovak Republic Roche Farmacêutica Química, Lda Estrada nacional 249-1, 2720-413, Amadora Roche Farmacêutica Química, Lda Estrada nacional 249-1, 2720-413, Amadora Roche Romania SRL 9-9A Dimitrie Pompei Street, Building 19, Entrance B, 3rd Floor, Sector (District) 2, Bucharest Romania Roche Romania SRL 9-9A Dimitrie Pompei Street, Building 19, Entrance B, 3rd Floor, Sector (District) 2, Bucharest Romania Roche Slovensko s.r.o. Cintorínska 3/A Bratislava Slovak Republic Roche Slovensko s.r.o. Cintorínska 3/A Bratislava Slovak Republic F.Hoffmann-La Roche Ltd. Basel, Switzerland Roche farmacevtska družba d.o.o. Vodovodna cesta 109 1000 Ljubljana Kytril Solution for Kytril 3 mg/3 ml Solution for Kytril 1 mg Kytril 3mg/3ml Solution for Kytril 1 mg Kytril 2 mg 2 mg Film-coated tablet Oral use Kytril INJ/INF Concentrate for infusion/ Kytril 2 mg filmsko 2 mg Film-coated tablet Oral use obložene tablete 1 ml () 3 ml (3 mg/3 ml) 3mg/3ml (1mg/ml) 8

Roche farmacevtska družba d.o.o. Vodovodna cesta 109 1000 Ljubljana Roche farmacevtska družba d.o.o. Vodovodna cesta 109 1000 Ljubljana Roche Farma S.A. C/ Eucalipto 33 28016 Madrid Roche Farma S.A. C/ Eucalipto 33 28016 Madrid Roche Farma S.A. C/ Eucalipto 33 28016 Madrid Roche AB Box 47327 100 74 Stockholm Roche AB Box 47327 100 74 Stockholm Roche AB Box 47327 100 74 Stockholm Kytril raztopina za injiciranje Kytril 3 mg/3 ml raztopina za injiciranje Kytril 1 mg comprimidos recubiertos con película Kytril solución inyectable Kytril 3 mg/3 ml solución inyectable Solution for 3 mg/3 ml Solution for 1mg/1ml 3mg/3ml Solution for Solution for Kytril Kytril Solution for 5 x 1 ml 5 x 3 ml 9

AL7 1TW AL7 1TW AL7 1TW AL7 1TW Kytril Tablets 1mg 1mg Film-coated tablet Oral use Kytril Tablets 2mg 2mg Film-coated tablet Oral use Kytril Ampoule 1mg/1ml 1mg/1ml Concentrate for infusion/ Kytril Infusion 3mg/ml 3mg/3ml Concentrate for infusion/ 1ml contains 1mg granisetron (hydrochloride 1mg of granisetron per 1 ml solution 10